These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 4976867

  • 21. Continuously propagated cell lines. Identification standards: serology.
    Brand KG.
    Natl Cancer Inst Monogr; 1968 Dec; 29():51-3. PubMed ID: 5720805
    [No Abstract] [Full Text] [Related]

  • 22. Detection of latent viruses.
    Rightsel WA.
    Natl Cancer Inst Monogr; 1968 Dec; 29():359-63. PubMed ID: 4976362
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT.
    Ann Ist Super Sanita; 1969 Dec; 5(1):82-9. PubMed ID: 5382315
    [No Abstract] [Full Text] [Related]

  • 26. Evidence for oncogenic properties of heteroploidy cell lines.
    Sanford KK.
    Natl Cancer Inst Monogr; 1968 Dec; 29():283-7. PubMed ID: 5720798
    [No Abstract] [Full Text] [Related]

  • 27. Vaccines produced in diploid cell lines--discussion.
    Perkins FT.
    Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
    [No Abstract] [Full Text] [Related]

  • 28. Experience with an established cell line for veterinary vaccine production.
    Brown AL.
    Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440
    [No Abstract] [Full Text] [Related]

  • 29. Technology of production of primary and diploid cell cultures.
    Brackett RG.
    Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
    [No Abstract] [Full Text] [Related]

  • 30. Detection of latent viruses in kidney tissues.
    Hsiung GD.
    Natl Cancer Inst Monogr; 1968 Dec; 29():351-3. PubMed ID: 4305433
    [No Abstract] [Full Text] [Related]

  • 31. Cell substrates for human virus vaccine preparation--general comments.
    Hayflick L.
    Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Blood group antigens in virus vaccines.
    Franks D, Dawson A.
    Natl Cancer Inst Monogr; 1968 Dec; 29():195-9. PubMed ID: 4888928
    [No Abstract] [Full Text] [Related]

  • 34. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.
    Yerganian G, Nell MA, Cho SS, Hayford AH, Ho T.
    Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757
    [No Abstract] [Full Text] [Related]

  • 35. Viral flora of chick and duck tissue sources.
    Luginbuhl RE.
    Natl Cancer Inst Monogr; 1968 Dec; 29():109-18. PubMed ID: 4305425
    [No Abstract] [Full Text] [Related]

  • 36. Karyologic characteristics of the WI-38 diploid cell system--general comments.
    Rubin BA, Minecci LC, Tint H.
    Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816
    [No Abstract] [Full Text] [Related]

  • 37. Characteristics of cell culture systems: primary cultures, diploid cell lines, and continuously propagated cell lines--summary.
    Evans VJ, Hanks JH.
    Natl Cancer Inst Monogr; 1968 Dec; 29():547-9. PubMed ID: 5720807
    [No Abstract] [Full Text] [Related]

  • 38. Comments on technology of production--continuous cell lines.
    Daniels WF.
    Natl Cancer Inst Monogr; 1968 Dec; 29():71-2. PubMed ID: 5720813
    [No Abstract] [Full Text] [Related]

  • 39. Latent viral infections in donor tissues and in recipients of vaccines.
    Melnick JL.
    Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432
    [No Abstract] [Full Text] [Related]

  • 40. Vaccines produced in heteroploid cell lines--discussion.
    Hull RN.
    Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.